Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels

It’s another wild twist in the story of Galapagos, a company that has been around for more than 25 years but has yet to get a therapy approved.

Scroll to Top